nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ABCC1—Glyburide—gestational diabetes	0.273	0.44	CbGbCtD
Vandetanib—ABCG2—Glyburide—gestational diabetes	0.183	0.294	CbGbCtD
Vandetanib—ALB—Glyburide—gestational diabetes	0.126	0.203	CbGbCtD
Vandetanib—CYP3A4—Glyburide—gestational diabetes	0.0394	0.0636	CbGbCtD
Vandetanib—KDR—umbilical vein—gestational diabetes	0.00775	0.0356	CbGeAlD
Vandetanib—STK35—islet of Langerhans—gestational diabetes	0.00343	0.0157	CbGeAlD
Vandetanib—RIPK2—islet of Langerhans—gestational diabetes	0.00316	0.0145	CbGeAlD
Vandetanib—VEGFA—islet of Langerhans—gestational diabetes	0.00315	0.0145	CbGeAlD
Vandetanib—IRAK4—islet of Langerhans—gestational diabetes	0.00309	0.0142	CbGeAlD
Vandetanib—FLT4—embryo—gestational diabetes	0.00308	0.0141	CbGeAlD
Vandetanib—ERBB3—embryo—gestational diabetes	0.00293	0.0134	CbGeAlD
Vandetanib—PTK6—vagina—gestational diabetes	0.00282	0.0129	CbGeAlD
Vandetanib—LTK—head—gestational diabetes	0.00272	0.0125	CbGeAlD
Vandetanib—RET—embryo—gestational diabetes	0.00271	0.0125	CbGeAlD
Vandetanib—FGR—embryo—gestational diabetes	0.00271	0.0125	CbGeAlD
Vandetanib—SLK—islet of Langerhans—gestational diabetes	0.00269	0.0123	CbGeAlD
Vandetanib—BMPR1B—uterus—gestational diabetes	0.00263	0.0121	CbGeAlD
Vandetanib—EPHA8—head—gestational diabetes	0.00261	0.012	CbGeAlD
Vandetanib—BMPR1B—adipose tissue—gestational diabetes	0.00257	0.0118	CbGeAlD
Vandetanib—MAP4K5—islet of Langerhans—gestational diabetes	0.00256	0.0117	CbGeAlD
Vandetanib—FYN—embryo—gestational diabetes	0.00253	0.0116	CbGeAlD
Vandetanib—TEK—embryo—gestational diabetes	0.00247	0.0113	CbGeAlD
Vandetanib—EPHB6—islet of Langerhans—gestational diabetes	0.00244	0.0112	CbGeAlD
Vandetanib—YES1—islet of Langerhans—gestational diabetes	0.00236	0.0108	CbGeAlD
Vandetanib—SRC—islet of Langerhans—gestational diabetes	0.00227	0.0104	CbGeAlD
Vandetanib—SRC—embryo—gestational diabetes	0.0022	0.0101	CbGeAlD
Vandetanib—STK35—adipose tissue—gestational diabetes	0.00219	0.01	CbGeAlD
Vandetanib—EPHA5—vagina—gestational diabetes	0.00218	0.01	CbGeAlD
Vandetanib—EPHA6—head—gestational diabetes	0.00217	0.00997	CbGeAlD
Vandetanib—ABL2—adipose tissue—gestational diabetes	0.00213	0.00978	CbGeAlD
Vandetanib—EGFR—uterus—gestational diabetes	0.00213	0.00976	CbGeAlD
Vandetanib—EGFR—adipose tissue—gestational diabetes	0.00208	0.00954	CbGeAlD
Vandetanib—VEGFA—uterus—gestational diabetes	0.00206	0.00943	CbGeAlD
Vandetanib—FLT4—adipose tissue—gestational diabetes	0.00203	0.0093	CbGeAlD
Vandetanib—KDR—embryo—gestational diabetes	0.00202	0.00927	CbGeAlD
Vandetanib—RIPK2—adipose tissue—gestational diabetes	0.00202	0.00925	CbGeAlD
Vandetanib—TYRO3—head—gestational diabetes	0.00202	0.00925	CbGeAlD
Vandetanib—EPHA5—head—gestational diabetes	0.00202	0.00925	CbGeAlD
Vandetanib—VEGFA—adipose tissue—gestational diabetes	0.00201	0.00923	CbGeAlD
Vandetanib—LYN—head—gestational diabetes	0.00201	0.0092	CbGeAlD
Vandetanib—FMO1—adipose tissue—gestational diabetes	0.002	0.00918	CbGeAlD
Vandetanib—BMPR1B—head—gestational diabetes	0.00198	0.00906	CbGeAlD
Vandetanib—MAP3K19—head—gestational diabetes	0.00198	0.00906	CbGeAlD
Vandetanib—ERBB3—uterus—gestational diabetes	0.00197	0.00905	CbGeAlD
Vandetanib—IRAK4—adipose tissue—gestational diabetes	0.00197	0.00903	CbGeAlD
Vandetanib—ERBB3—adipose tissue—gestational diabetes	0.00193	0.00885	CbGeAlD
Vandetanib—LCK—uterus—gestational diabetes	0.00183	0.0084	CbGeAlD
Vandetanib—AXL—uterus—gestational diabetes	0.00182	0.00836	CbGeAlD
Vandetanib—STK35—vagina—gestational diabetes	0.00182	0.00834	CbGeAlD
Vandetanib—MKNK1—adipose tissue—gestational diabetes	0.00181	0.00831	CbGeAlD
Vandetanib—PDGFRB—islet of Langerhans—gestational diabetes	0.00181	0.0083	CbGeAlD
Vandetanib—FGR—adipose tissue—gestational diabetes	0.00179	0.00821	CbGeAlD
Vandetanib—LCK—adipose tissue—gestational diabetes	0.00179	0.00821	CbGeAlD
Vandetanib—AXL—adipose tissue—gestational diabetes	0.00178	0.00818	CbGeAlD
Vandetanib—ABL2—vagina—gestational diabetes	0.00177	0.00813	CbGeAlD
Vandetanib—SLK—uterus—gestational diabetes	0.00176	0.00805	CbGeAlD
Vandetanib—PDGFRB—embryo—gestational diabetes	0.00175	0.00802	CbGeAlD
Vandetanib—FMO3—adipose tissue—gestational diabetes	0.00173	0.00793	CbGeAlD
Vandetanib—SLK—adipose tissue—gestational diabetes	0.00172	0.00787	CbGeAlD
Vandetanib—FYN—uterus—gestational diabetes	0.00171	0.00783	CbGeAlD
Vandetanib—STK35—head—gestational diabetes	0.00168	0.0077	CbGeAlD
Vandetanib—RIPK2—vagina—gestational diabetes	0.00168	0.00769	CbGeAlD
Vandetanib—VEGFA—vagina—gestational diabetes	0.00167	0.00767	CbGeAlD
Vandetanib—FYN—adipose tissue—gestational diabetes	0.00167	0.00766	CbGeAlD
Vandetanib—MAP4K5—uterus—gestational diabetes	0.00167	0.00765	CbGeAlD
Vandetanib—TEK—uterus—gestational diabetes	0.00167	0.00765	CbGeAlD
Vandetanib—FMO1—vagina—gestational diabetes	0.00166	0.00763	CbGeAlD
Vandetanib—Nephropathy—Glyburide—gestational diabetes	0.00166	0.147	CcSEcCtD
Vandetanib—IRAK4—vagina—gestational diabetes	0.00164	0.00751	CbGeAlD
Vandetanib—TEK—adipose tissue—gestational diabetes	0.00163	0.00748	CbGeAlD
Vandetanib—MAP4K5—adipose tissue—gestational diabetes	0.00163	0.00748	CbGeAlD
Vandetanib—ABL1—islet of Langerhans—gestational diabetes	0.00161	0.0074	CbGeAlD
Vandetanib—ABL1—embryo—gestational diabetes	0.00156	0.00715	CbGeAlD
Vandetanib—EPHB6—adipose tissue—gestational diabetes	0.00156	0.00715	CbGeAlD
Vandetanib—FLT4—head—gestational diabetes	0.00156	0.00714	CbGeAlD
Vandetanib—RIPK2—head—gestational diabetes	0.00155	0.0071	CbGeAlD
Vandetanib—YES1—uterus—gestational diabetes	0.00154	0.00706	CbGeAlD
Vandetanib—FMO1—head—gestational diabetes	0.00154	0.00705	CbGeAlD
Vandetanib—STK10—uterus—gestational diabetes	0.00153	0.007	CbGeAlD
Vandetanib—IRAK4—head—gestational diabetes	0.00151	0.00694	CbGeAlD
Vandetanib—MKNK1—vagina—gestational diabetes	0.00151	0.00691	CbGeAlD
Vandetanib—YES1—adipose tissue—gestational diabetes	0.00151	0.00691	CbGeAlD
Vandetanib—STK10—adipose tissue—gestational diabetes	0.00149	0.00685	CbGeAlD
Vandetanib—FGR—vagina—gestational diabetes	0.00149	0.00683	CbGeAlD
Vandetanib—LCK—vagina—gestational diabetes	0.00149	0.00683	CbGeAlD
Vandetanib—ERBB3—head—gestational diabetes	0.00148	0.0068	CbGeAlD
Vandetanib—AXL—vagina—gestational diabetes	0.00148	0.0068	CbGeAlD
Vandetanib—SRC—adipose tissue—gestational diabetes	0.00145	0.00665	CbGeAlD
Vandetanib—FMO3—vagina—gestational diabetes	0.00144	0.00659	CbGeAlD
Vandetanib—SLK—vagina—gestational diabetes	0.00143	0.00655	CbGeAlD
Vandetanib—MKNK1—head—gestational diabetes	0.00139	0.00638	CbGeAlD
Vandetanib—FYN—vagina—gestational diabetes	0.00139	0.00636	CbGeAlD
Vandetanib—FGR—head—gestational diabetes	0.00137	0.00631	CbGeAlD
Vandetanib—RET—head—gestational diabetes	0.00137	0.00631	CbGeAlD
Vandetanib—AXL—head—gestational diabetes	0.00137	0.00628	CbGeAlD
Vandetanib—KDR—uterus—gestational diabetes	0.00136	0.00625	CbGeAlD
Vandetanib—MAP4K5—vagina—gestational diabetes	0.00136	0.00622	CbGeAlD
Vandetanib—KDR—adipose tissue—gestational diabetes	0.00133	0.00611	CbGeAlD
Vandetanib—MAP2K5—adipose tissue—gestational diabetes	0.00133	0.00611	CbGeAlD
Vandetanib—FMO3—head—gestational diabetes	0.00133	0.00609	CbGeAlD
Vandetanib—EPHB6—vagina—gestational diabetes	0.0013	0.00594	CbGeAlD
Vandetanib—FYN—head—gestational diabetes	0.00128	0.00588	CbGeAlD
Vandetanib—TEK—head—gestational diabetes	0.00125	0.00574	CbGeAlD
Vandetanib—MAP4K5—head—gestational diabetes	0.00125	0.00574	CbGeAlD
Vandetanib—YES1—vagina—gestational diabetes	0.00125	0.00574	CbGeAlD
Vandetanib—STK10—vagina—gestational diabetes	0.00124	0.00569	CbGeAlD
Vandetanib—EPHB6—head—gestational diabetes	0.0012	0.00549	CbGeAlD
Vandetanib—PDGFRB—uterus—gestational diabetes	0.00118	0.00541	CbGeAlD
Vandetanib—YES1—head—gestational diabetes	0.00116	0.00531	CbGeAlD
Vandetanib—PDGFRB—adipose tissue—gestational diabetes	0.00115	0.00529	CbGeAlD
Vandetanib—STK10—head—gestational diabetes	0.00115	0.00526	CbGeAlD
Vandetanib—SRC—head—gestational diabetes	0.00111	0.0051	CbGeAlD
Vandetanib—MAP2K5—vagina—gestational diabetes	0.00111	0.00508	CbGeAlD
Vandetanib—KDR—vagina—gestational diabetes	0.00111	0.00508	CbGeAlD
Vandetanib—ABL1—uterus—gestational diabetes	0.00105	0.00482	CbGeAlD
Vandetanib—ABL1—adipose tissue—gestational diabetes	0.00103	0.00472	CbGeAlD
Vandetanib—MAP2K5—head—gestational diabetes	0.00102	0.00469	CbGeAlD
Vandetanib—KDR—head—gestational diabetes	0.00102	0.00469	CbGeAlD
Vandetanib—PDGFRB—vagina—gestational diabetes	0.000959	0.0044	CbGeAlD
Vandetanib—PDGFRB—head—gestational diabetes	0.000886	0.00406	CbGeAlD
Vandetanib—ABL1—vagina—gestational diabetes	0.000855	0.00392	CbGeAlD
Vandetanib—ABCC1—uterus—gestational diabetes	0.000801	0.00367	CbGeAlD
Vandetanib—ABL1—head—gestational diabetes	0.00079	0.00362	CbGeAlD
Vandetanib—ABCC1—adipose tissue—gestational diabetes	0.000783	0.00359	CbGeAlD
Vandetanib—ABCG2—uterus—gestational diabetes	0.000663	0.00304	CbGeAlD
Vandetanib—ABCC1—vagina—gestational diabetes	0.000651	0.00299	CbGeAlD
Vandetanib—ABCG2—adipose tissue—gestational diabetes	0.000648	0.00297	CbGeAlD
Vandetanib—Dermatitis bullous—Glyburide—gestational diabetes	0.000601	0.0531	CcSEcCtD
Vandetanib—Hypoglycaemia—Glyburide—gestational diabetes	0.000588	0.052	CcSEcCtD
Vandetanib—Hyponatraemia—Glyburide—gestational diabetes	0.000576	0.0509	CcSEcCtD
Vandetanib—ABCG2—vagina—gestational diabetes	0.000539	0.00247	CbGeAlD
Vandetanib—Pancreatitis—Glyburide—gestational diabetes	0.000486	0.043	CcSEcCtD
Vandetanib—Photosensitivity reaction—Glyburide—gestational diabetes	0.000453	0.04	CcSEcCtD
Vandetanib—Visual impairment—Glyburide—gestational diabetes	0.000383	0.0338	CcSEcCtD
Vandetanib—Eye disorder—Glyburide—gestational diabetes	0.000371	0.0328	CcSEcCtD
Vandetanib—Alopecia—Glyburide—gestational diabetes	0.000351	0.031	CcSEcCtD
Vandetanib—Malnutrition—Glyburide—gestational diabetes	0.000346	0.0305	CcSEcCtD
Vandetanib—Vision blurred—Glyburide—gestational diabetes	0.000326	0.0288	CcSEcCtD
Vandetanib—Tremor—Glyburide—gestational diabetes	0.000324	0.0286	CcSEcCtD
Vandetanib—Convulsion—Glyburide—gestational diabetes	0.0003	0.0265	CcSEcCtD
Vandetanib—Arthralgia—Glyburide—gestational diabetes	0.000294	0.026	CcSEcCtD
Vandetanib—Oedema—Glyburide—gestational diabetes	0.000282	0.0249	CcSEcCtD
Vandetanib—Nervous system disorder—Glyburide—gestational diabetes	0.000277	0.0244	CcSEcCtD
Vandetanib—Thrombocytopenia—Glyburide—gestational diabetes	0.000276	0.0244	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000257	0.0227	CcSEcCtD
Vandetanib—Paraesthesia—Glyburide—gestational diabetes	0.000253	0.0224	CcSEcCtD
Vandetanib—Dyspnoea—Glyburide—gestational diabetes	0.000252	0.0222	CcSEcCtD
Vandetanib—Dyspepsia—Glyburide—gestational diabetes	0.000248	0.0219	CcSEcCtD
Vandetanib—Decreased appetite—Glyburide—gestational diabetes	0.000245	0.0217	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000244	0.0215	CcSEcCtD
Vandetanib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000231	0.0204	CcSEcCtD
Vandetanib—Abdominal pain—Glyburide—gestational diabetes	0.000223	0.0197	CcSEcCtD
Vandetanib—Asthenia—Glyburide—gestational diabetes	0.000202	0.0179	CcSEcCtD
Vandetanib—Pruritus—Glyburide—gestational diabetes	0.0002	0.0176	CcSEcCtD
Vandetanib—Diarrhoea—Glyburide—gestational diabetes	0.000193	0.0171	CcSEcCtD
Vandetanib—Vomiting—Glyburide—gestational diabetes	0.000179	0.0158	CcSEcCtD
Vandetanib—Rash—Glyburide—gestational diabetes	0.000178	0.0157	CcSEcCtD
Vandetanib—Dermatitis—Glyburide—gestational diabetes	0.000178	0.0157	CcSEcCtD
Vandetanib—Headache—Glyburide—gestational diabetes	0.000177	0.0156	CcSEcCtD
Vandetanib—Nausea—Glyburide—gestational diabetes	0.000168	0.0148	CcSEcCtD
Vandetanib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000139	0.000928	CbGpPWpGaD
Vandetanib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.000138	0.000921	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—NAMPT—gestational diabetes	0.000138	0.000918	CbGpPWpGaD
Vandetanib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.000138	0.000917	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—GCK—gestational diabetes	0.000137	0.000912	CbGpPWpGaD
Vandetanib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000137	0.000912	CbGpPWpGaD
Vandetanib—FYN—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000136	0.000908	CbGpPWpGaD
Vandetanib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000136	0.000908	CbGpPWpGaD
Vandetanib—SRC—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000136	0.000907	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—LEPR—gestational diabetes	0.000136	0.000906	CbGpPWpGaD
Vandetanib—YES1—Immune System—MBL2—gestational diabetes	0.000136	0.000905	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000136	0.000904	CbGpPWpGaD
Vandetanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000134	0.000895	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GGCT—gestational diabetes	0.000133	0.00089	CbGpPWpGaD
Vandetanib—EGFR—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000133	0.000886	CbGpPWpGaD
Vandetanib—EGFR—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000133	0.000886	CbGpPWpGaD
Vandetanib—EGFR—DAP12 interactions—FGF2—gestational diabetes	0.000133	0.000886	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—LEPR—gestational diabetes	0.000132	0.000882	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR—FGF2—gestational diabetes	0.000132	0.000878	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—LEPR—gestational diabetes	0.000131	0.000873	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000131	0.00087	CbGpPWpGaD
Vandetanib—EGFR—Signaling by PDGF—FGF2—gestational diabetes	0.00013	0.000867	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NAMPT—gestational diabetes	0.000129	0.000861	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—GCK—gestational diabetes	0.000128	0.000856	CbGpPWpGaD
Vandetanib—ERBB3—Disease—GCK—gestational diabetes	0.000128	0.000856	CbGpPWpGaD
Vandetanib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000128	0.000854	CbGpPWpGaD
Vandetanib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000128	0.000854	CbGpPWpGaD
Vandetanib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000128	0.000854	CbGpPWpGaD
Vandetanib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.000127	0.000846	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—MBL2—gestational diabetes	0.000126	0.000841	CbGpPWpGaD
Vandetanib—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000126	0.000841	CbGpPWpGaD
Vandetanib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000126	0.000839	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—LEP—gestational diabetes	0.000126	0.000838	CbGpPWpGaD
Vandetanib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000125	0.000835	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000125	0.000834	CbGpPWpGaD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000124	0.000829	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—ADIPOQ—gestational diabetes	0.000124	0.000826	CbGpPWpGaD
Vandetanib—EGFR—B Cell Activation—FGF2—gestational diabetes	0.000123	0.00082	CbGpPWpGaD
Vandetanib—SRC—Downstream signal transduction—FGF2—gestational diabetes	0.000122	0.000815	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR—FGF2—gestational diabetes	0.000122	0.000811	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—LEP—gestational diabetes	0.000121	0.000809	CbGpPWpGaD
Vandetanib—SRC—Signaling by ERBB2—FGF2—gestational diabetes	0.000121	0.000807	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000119	0.000795	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—LEPR—gestational diabetes	0.000119	0.000793	CbGpPWpGaD
Vandetanib—LCK—B Cell Activation—FGF2—gestational diabetes	0.000119	0.00079	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—TNF—gestational diabetes	0.000118	0.000787	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—TNF—gestational diabetes	0.000118	0.000787	CbGpPWpGaD
Vandetanib—EGFR—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000118	0.000785	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000117	0.000783	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.000783	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GLS2—gestational diabetes	0.000117	0.000778	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—FGF2—gestational diabetes	0.000116	0.000776	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—LEPR—gestational diabetes	0.000115	0.000766	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.000763	CbGpPWpGaD
Vandetanib—EPHA8—Developmental Biology—TNF—gestational diabetes	0.000114	0.000759	CbGpPWpGaD
Vandetanib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000113	0.000756	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000113	0.000756	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR—FGF2—gestational diabetes	0.000112	0.000749	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—LEP—gestational diabetes	0.000112	0.000746	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—TNF—gestational diabetes	0.000112	0.000746	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000111	0.000743	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—FGF2—gestational diabetes	0.000111	0.000739	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.000109	0.000725	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	0.000107	0.000716	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000107	0.000711	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—FGF2—gestational diabetes	0.000106	0.000708	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—TNF—gestational diabetes	0.000106	0.000706	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—ADIPOQ—gestational diabetes	0.000106	0.000705	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—FGF2—gestational diabetes	0.000105	0.000701	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—FGF2—gestational diabetes	0.000105	0.000699	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MTNR1B—gestational diabetes	0.000105	0.000698	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	0.000105	0.000698	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000104	0.000695	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MTNR1B—gestational diabetes	0.000104	0.00069	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MBL2—gestational diabetes	0.000103	0.00069	CbGpPWpGaD
Vandetanib—ALB—Folate Metabolism—TNF—gestational diabetes	0.000103	0.000684	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GLS2—gestational diabetes	0.000103	0.000684	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—LEP—gestational diabetes	0.000102	0.000683	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—RBP4—gestational diabetes	0.000102	0.00068	CbGpPWpGaD
Vandetanib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000101	0.000676	CbGpPWpGaD
Vandetanib—LYN—Immune System—MBL2—gestational diabetes	0.000101	0.000675	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—FGF2—gestational diabetes	0.000101	0.000674	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—FGF2—gestational diabetes	0.000101	0.000673	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—RBP4—gestational diabetes	0.000101	0.000672	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MBL2—gestational diabetes	0.000101	0.000672	CbGpPWpGaD
Vandetanib—SRC—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.0001	0.00067	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—CYP19A1—gestational diabetes	0.0001	0.000667	CbGpPWpGaD
Vandetanib—FYN—Immune System—MBL2—gestational diabetes	9.97e-05	0.000665	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—TNF—gestational diabetes	9.96e-05	0.000663	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MTNR1B—gestational diabetes	9.76e-05	0.00065	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—FGF2—gestational diabetes	9.72e-05	0.000648	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—RBP4—gestational diabetes	9.63e-05	0.000642	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—FGF2—gestational diabetes	9.55e-05	0.000636	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MTNR1B—gestational diabetes	9.41e-05	0.000627	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—LEP—gestational diabetes	9.37e-05	0.000624	CbGpPWpGaD
Vandetanib—FYN—Disease—RBP4—gestational diabetes	9.28e-05	0.000619	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—FGF2—gestational diabetes	9.28e-05	0.000618	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—FGF2—gestational diabetes	9.22e-05	0.000615	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—RBP4—gestational diabetes	9.17e-05	0.000611	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MTNR1B—gestational diabetes	9.09e-05	0.000606	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—FGF2—gestational diabetes	9.06e-05	0.000604	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—LEP—gestational diabetes	9.05e-05	0.000603	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—LEP—gestational diabetes	9.01e-05	0.000601	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	8.91e-05	0.000594	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—LEP—gestational diabetes	8.91e-05	0.000594	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—FGF2—gestational diabetes	8.91e-05	0.000594	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RBP4—gestational diabetes	8.86e-05	0.00059	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	8.76e-05	0.000584	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—FGF2—gestational diabetes	8.73e-05	0.000582	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NAMPT—gestational diabetes	8.64e-05	0.000576	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MBL2—gestational diabetes	8.62e-05	0.000574	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—GCK—gestational diabetes	8.58e-05	0.000572	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—LEPR—gestational diabetes	8.57e-05	0.000571	CbGpPWpGaD
Vandetanib—ABCC1—Disease—RBP4—gestational diabetes	8.51e-05	0.000567	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—FGF2—gestational diabetes	8.51e-05	0.000567	CbGpPWpGaD
Vandetanib—EGFR—MAPK Signaling Pathway—TNF—gestational diabetes	8.44e-05	0.000563	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—LEPR—gestational diabetes	8.44e-05	0.000562	CbGpPWpGaD
Vandetanib—MKNK1—Disease—FGF2—gestational diabetes	8.42e-05	0.000561	CbGpPWpGaD
Vandetanib—FYN—Disease—NAMPT—gestational diabetes	8.33e-05	0.000555	CbGpPWpGaD
Vandetanib—LCK—Immune System—MBL2—gestational diabetes	8.3e-05	0.000553	CbGpPWpGaD
Vandetanib—FYN—Disease—GCK—gestational diabetes	8.27e-05	0.000551	CbGpPWpGaD
Vandetanib—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	8.16e-05	0.000544	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—FGF2—gestational diabetes	8.15e-05	0.000543	CbGpPWpGaD
Vandetanib—EGFR—Disease—RBP4—gestational diabetes	8.02e-05	0.000535	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.96e-05	0.000531	CbGpPWpGaD
Vandetanib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	7.85e-05	0.000523	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—FGF2—gestational diabetes	7.82e-05	0.000521	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—FGF2—gestational diabetes	7.78e-05	0.000519	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—LEP—gestational diabetes	7.76e-05	0.000517	CbGpPWpGaD
Vandetanib—LCK—Disease—RBP4—gestational diabetes	7.73e-05	0.000515	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—FGF2—gestational diabetes	7.73e-05	0.000515	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—LEP—gestational diabetes	7.7e-05	0.000513	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NAMPT—gestational diabetes	7.63e-05	0.000509	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.62e-05	0.000508	CbGpPWpGaD
Vandetanib—ABCC1—Disease—GCK—gestational diabetes	7.58e-05	0.000505	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	7.36e-05	0.000491	CbGpPWpGaD
Vandetanib—SRC—Immune System—MBL2—gestational diabetes	7.35e-05	0.00049	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LEPR—gestational diabetes	7.29e-05	0.000486	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GGCT—gestational diabetes	7.25e-05	0.000483	CbGpPWpGaD
Vandetanib—EGFR—Disease—NAMPT—gestational diabetes	7.19e-05	0.000479	CbGpPWpGaD
Vandetanib—EGFR—Disease—GCK—gestational diabetes	7.15e-05	0.000476	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—FGF2—gestational diabetes	7.12e-05	0.000474	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LEPR—gestational diabetes	7.03e-05	0.000468	CbGpPWpGaD
Vandetanib—LCK—Disease—NAMPT—gestational diabetes	6.93e-05	0.000462	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	6.92e-05	0.000461	CbGpPWpGaD
Vandetanib—LCK—Disease—GCK—gestational diabetes	6.89e-05	0.000459	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—FGF2—gestational diabetes	6.88e-05	0.000458	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—FGF2—gestational diabetes	6.84e-05	0.000456	CbGpPWpGaD
Vandetanib—SRC—Disease—RBP4—gestational diabetes	6.84e-05	0.000456	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—FGF2—gestational diabetes	6.78e-05	0.000452	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	6.78e-05	0.000452	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—FGF2—gestational diabetes	6.77e-05	0.000451	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	6.74e-05	0.00045	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MTNR1B—gestational diabetes	6.67e-05	0.000445	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RBP4—gestational diabetes	6.6e-05	0.00044	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—LEP—gestational diabetes	6.57e-05	0.000438	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RBP4—gestational diabetes	6.5e-05	0.000433	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.5e-05	0.000433	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—TNF—gestational diabetes	6.47e-05	0.000431	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NAMPT—gestational diabetes	6.39e-05	0.000426	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GCK—gestational diabetes	6.35e-05	0.000423	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GLS2—gestational diabetes	6.33e-05	0.000422	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LEPR—gestational diabetes	6.22e-05	0.000415	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	6.2e-05	0.000413	CbGpPWpGaD
Vandetanib—SRC—Disease—NAMPT—gestational diabetes	6.14e-05	0.000409	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—FGF2—gestational diabetes	6.13e-05	0.000409	CbGpPWpGaD
Vandetanib—SRC—Disease—GCK—gestational diabetes	6.1e-05	0.000406	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—FGF2—gestational diabetes	6.07e-05	0.000405	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—FGF2—gestational diabetes	6.05e-05	0.000403	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—FGF2—gestational diabetes	5.98e-05	0.000399	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	5.96e-05	0.000397	CbGpPWpGaD
Vandetanib—BLK—Immune System—FGF2—gestational diabetes	5.9e-05	0.000393	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—FGF2—gestational diabetes	5.9e-05	0.000393	CbGpPWpGaD
Vandetanib—FGR—Immune System—FGF2—gestational diabetes	5.88e-05	0.000392	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—FGF2—gestational diabetes	5.85e-05	0.00039	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—FGF2—gestational diabetes	5.83e-05	0.000389	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—TNF—gestational diabetes	5.81e-05	0.000387	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MTNR1B—gestational diabetes	5.76e-05	0.000384	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—FGF2—gestational diabetes	5.74e-05	0.000383	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.66e-05	0.000377	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NAMPT—gestational diabetes	5.62e-05	0.000375	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RBP4—gestational diabetes	5.62e-05	0.000374	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—TNF—gestational diabetes	5.62e-05	0.000374	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GCK—gestational diabetes	5.59e-05	0.000373	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	5.55e-05	0.00037	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RBP4—gestational diabetes	5.41e-05	0.000361	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—FGF2—gestational diabetes	5.4e-05	0.00036	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—LEP—gestational diabetes	5.22e-05	0.000348	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—FGF2—gestational diabetes	5.17e-05	0.000344	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—FGF2—gestational diabetes	4.99e-05	0.000333	CbGpPWpGaD
Vandetanib—ERBB3—Disease—FGF2—gestational diabetes	4.99e-05	0.000333	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—FGF2—gestational diabetes	4.98e-05	0.000332	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—FGF2—gestational diabetes	4.96e-05	0.000331	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MTNR1B—gestational diabetes	4.92e-05	0.000328	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RBP4—gestational diabetes	4.79e-05	0.000319	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—FGF2—gestational diabetes	4.78e-05	0.000319	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	4.77e-05	0.000318	CbGpPWpGaD
Vandetanib—YES1—Immune System—FGF2—gestational diabetes	4.74e-05	0.000316	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—LEP—gestational diabetes	4.65e-05	0.00031	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CYP19A1—gestational diabetes	4.64e-05	0.00031	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—LEP—gestational diabetes	4.6e-05	0.000307	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—FGF2—gestational diabetes	4.41e-05	0.000294	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—FGF2—gestational diabetes	4.23e-05	0.000282	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TNF—gestational diabetes	4.19e-05	0.000279	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—LEP—gestational diabetes	4.18e-05	0.000279	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TNF—gestational diabetes	4.17e-05	0.000278	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TNF—gestational diabetes	4.12e-05	0.000275	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.09e-05	0.000272	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—LEP—gestational diabetes	4.04e-05	0.000269	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—FGF2—gestational diabetes	3.96e-05	0.000264	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GGCT—gestational diabetes	3.91e-05	0.000261	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	3.62e-05	0.000242	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—FGF2—gestational diabetes	3.61e-05	0.000241	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TNF—gestational diabetes	3.56e-05	0.000237	CbGpPWpGaD
Vandetanib—LYN—Immune System—FGF2—gestational diabetes	3.54e-05	0.000236	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—FGF2—gestational diabetes	3.53e-05	0.000235	CbGpPWpGaD
Vandetanib—ABL1—Immune System—FGF2—gestational diabetes	3.52e-05	0.000235	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—FGF2—gestational diabetes	3.49e-05	0.000233	CbGpPWpGaD
Vandetanib—FYN—Immune System—FGF2—gestational diabetes	3.48e-05	0.000232	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NAMPT—gestational diabetes	3.47e-05	0.000231	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GCK—gestational diabetes	3.45e-05	0.00023	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.42e-05	0.000228	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—FGF2—gestational diabetes	3.34e-05	0.000222	CbGpPWpGaD
Vandetanib—FYN—Disease—FGF2—gestational diabetes	3.22e-05	0.000214	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—FGF2—gestational diabetes	3.18e-05	0.000212	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	3.08e-05	0.000205	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—FGF2—gestational diabetes	3.07e-05	0.000204	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—gestational diabetes	3.04e-05	0.000203	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—LEP—gestational diabetes	3.01e-05	0.000201	CbGpPWpGaD
Vandetanib—EGFR—Immune System—FGF2—gestational diabetes	3.01e-05	0.000201	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—LEP—gestational diabetes	2.96e-05	0.000198	CbGpPWpGaD
Vandetanib—ABCC1—Disease—FGF2—gestational diabetes	2.95e-05	0.000196	CbGpPWpGaD
Vandetanib—LCK—Immune System—FGF2—gestational diabetes	2.9e-05	0.000193	CbGpPWpGaD
Vandetanib—EGFR—Disease—FGF2—gestational diabetes	2.78e-05	0.000185	CbGpPWpGaD
Vandetanib—LCK—Disease—FGF2—gestational diabetes	2.68e-05	0.000178	CbGpPWpGaD
Vandetanib—SRC—Immune System—FGF2—gestational diabetes	2.57e-05	0.000171	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LEP—gestational diabetes	2.56e-05	0.000171	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP19A1—gestational diabetes	2.52e-05	0.000168	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LEP—gestational diabetes	2.47e-05	0.000164	CbGpPWpGaD
Vandetanib—SRC—Disease—FGF2—gestational diabetes	2.37e-05	0.000158	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.34e-05	0.000156	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—FGF2—gestational diabetes	2.29e-05	0.000152	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—FGF2—gestational diabetes	2.25e-05	0.00015	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LEP—gestational diabetes	2.18e-05	0.000146	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—FGF2—gestational diabetes	1.95e-05	0.00013	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—FGF2—gestational diabetes	1.87e-05	0.000125	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.87e-05	0.000125	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GCK—gestational diabetes	1.86e-05	0.000124	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—FGF2—gestational diabetes	1.66e-05	0.000111	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.36e-05	9.07e-05	CbGpPWpGaD
